Inhalant dependence with unspecified inhalant-induced disorder
ICD-10 F18.29 is a billable code used to indicate a diagnosis of inhalant dependence with unspecified inhalant-induced disorder.
Inhalant dependence is characterized by a compulsive pattern of inhalant use that leads to significant impairment or distress. This condition is often associated with the inhalation of volatile substances such as solvents, aerosols, and gases, which can produce psychoactive effects. Individuals with inhalant dependence may experience cravings, tolerance, and withdrawal symptoms when not using the substance. The unspecified inhalant-induced disorder indicates that the specific effects of inhalant use, such as mood disturbances or cognitive impairments, have not been clearly defined. Clinically, inhalant dependence can lead to severe health consequences, including neurological damage, respiratory issues, and cardiovascular problems. Treatment typically involves behavioral therapies, counseling, and support groups, as pharmacological interventions are limited. Understanding the nuances of inhalant dependence is crucial for effective diagnosis and treatment, as well as for accurate coding in medical records.
Comprehensive substance use history, including types of inhalants used and frequency.
Patients presenting with acute intoxication or withdrawal symptoms.
Consideration of co-occurring mental health disorders and their impact on treatment.
Detailed mental status examination and assessment of functional impairment.
Patients with mood disorders or cognitive impairments related to inhalant use.
Need for thorough evaluation of psychosocial factors influencing substance use.
Used during initial evaluation of inhalant dependence.
Detailed history of substance use and assessment of severity.
Addiction specialists should ensure comprehensive evaluations.
Symptoms include cravings for inhalants, tolerance to their effects, withdrawal symptoms when not using, and continued use despite negative consequences.
